SCHEMBL4390734

SCHEMBL4390734

CC1CC(c2ccccc2)(c2ccccc2)CN1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 5/20 0.48
DRD4 P21917 1/20 0.48
KCNH2 Q12809 2/20 0.45
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HTT P42858 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
OPRD1 P41143 3/20 0.40
OPRK1 P41145 3/20 0.40
GRIN2D O15399 1/20 0.39
GRIN3B O60391 1/20 0.39
CHRM2 P08172 1/20 0.39
CHRM1 P11229 1/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2A Q12879 1/20 0.39
GRIN2B Q13224 1/20 0.39
GRIN2C Q14957 1/20 0.39
GRIN3A Q8TCU5 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17666180 0.78 SMN1; SMN2 (0.44) OPRM1DRD4KCNH2LMNASMN1; SMN2
SCHEMBL4395771 0.78 OPRM1 (0.43) OPRM1DRD4KCNH2LMNASMN1; SMN2
SCHEMBL4395795 0.75 MAPT (0.42) OPRM1DRD4LMNAOPRD1OPRK1
SCHEMBL4401474 0.75 MAPT (0.45) OPRM1LMNAOPRD1OPRK1MAPT
SCHEMBL26568813 0.73 PDK2 (0.49) OPRM1LMNAALDH1A1HTTOPRK1
SCHEMBL12367138 0.72 OPRM1 (0.69) OPRM1DRD4KCNH2LMNASMN1; SMN2
SCHEMBL11949296 0.71 LMNA (0.44) OPRM1LMNAALDH1A1MAPT
SCHEMBL4396595 0.71 CYP3A4 (0.42) OPRM1ALDH1A1OPRD1OPRK1MAPT
SCHEMBL4396042 0.71 SIGMAR1 (0.41) OPRM1DRD4ALDH1A1CHRM2MAPT
SCHEMBL15037443 0.71 SLC18A3 (0.44) OPRM1DRD4KCNH2SMN1; SMN2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156824-A1 Hydroamination of Alkenes BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) 2009-06-18 US claimed
US-12590054-B2 Use of D9-methadone for postoperative pain relief BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2026-03-31 US disclosed
CN-107664693-B Carrier for preventing flooding of detection reagent strips 杭州博拓生物科技股份有限公司 2025-05-27 CN disclosed
CN-107664702-B Device for detecting analyte in sample 杭州博拓生物科技股份有限公司 2025-04-01 CN disclosed
US-20240116851-A1 USE OF D9-METHADONE FOR POSTOPERATIVE PAIN RELIEF UNIV TEXAS (US) 2024-04-11 US disclosed
WO-2016040822-A1 READY-TO-CONSTITUTE ANALYTICAL PLATFORMS FOR CHEMICAL ANALYSES AND QUANTIFICATION PINPOINT TESTING, LLC (US) 2016-03-17 WO disclosed
US-20120190854-A1 Hydroamination of Alkenes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-07-26 US disclosed
US-20120190854-A1 Hydroamination of Alkenes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-07-26 US disclosed
US-20120190854-A1 Hydroamination of Alkenes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-07-26 US disclosed
US-8188302-B2 Hydroamination of alkenes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-05-29 US disclosed
US-8188302-B2 Hydroamination of alkenes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-05-29 US disclosed
US-8188302-B2 Hydroamination of alkenes THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2012-05-29 US disclosed
US-20090156824-A1 Hydroamination of Alkenes BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) 2009-06-18 US disclosed
US-20090156824-A1 Hydroamination of Alkenes BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) 2009-06-18 US disclosed
US-20090156824-A1 Hydroamination of Alkenes BOARD OF TRUSTEES OF UNIVERSITY OF ILLINOIS (US) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240116851-A1 USE OF D9-METHADONE FOR POSTOPERATIVE PAIN RELIEF OPRM1, OPRD1, OPRK1 OPRM1 1/4885DRD4 46/4885KCNH2 587/4885
US-20090156824-A1 Hydroamination of Alkenes HRH3, HRH4, H1-3 OPRM1 465/4885DRD4 272/4885KCNH2 1221/4885
US-12590054-B2 Use of D9-methadone for postoperative pain relief OPRM1, OPRD1, OPRK1 OPRM1 1/4885DRD4 97/4885KCNH2 447/4885
US-20120190854-A1 Hydroamination of Alkenes HRH3, HRH4, H1-3 OPRM1 465/4885DRD4 272/4885KCNH2 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.